ASH 2019 Interview - Dr Collin Chin - CAR T-cell therapy in aggressive lymphomas
ASH 2019 Interview - Dr John Leonard - highlights from the meeting for lymphoma
ASH 2019 Interview - A/Prof Chan Cheah - Aggressive Lymphoma, Diffuse Large B Cell lymphomas
ASH 2019 Interview - Prof John Gribben and Deborah Sims - Overview of CLL treatment
ASH 2019 Interview - Dr Jessica Hochberg - Chemotherapy, Young Adults & Hodgkin Lymphoma
ASH 2019 Interview - Dr George Follows - CLL updates
ASH 2019 Interview - Prof Peter Hillmen - Treatment – patient choice
ASH 2019 Interview - Dr Laurie Sehn - Update: Novel Therapies in Lymphoma
ASH 2019 Interview - Prof John Seymour - Overview of the Murano study – CLL/SLL
ASH 2019 Interview - Dr George Follows - Lymphoma updates
ASH 2019 Interview-Prof Mathias Rummel & Donna Gairns -Waldenstrom’s Macroglobulinaemia & STiL trial
ASH 2019 Interview - Dr Jason Westin - Diffuse Large B-cell Lymphoma updates & the Smart Start Study
ASH 2019 Interview -Prof Stephan Stilgenbauer and Deborah Sims- Updates on the management of CLL/SLL
ASH 2019 Interview - Prof Andrew Evens - HoLISTIC Hodgkin Lymphoma International Study
ASH 2019 Interview - Dr Loretta Nastoupil, CAR T-cell therapy clinical trials update
ASH 2019 Interview - Prof Peter Hillmen - Challenges in the CLL/SLL treatment landscape
ASH 2019 Interview - A/Prof Constantine Tam and Deborah Sims - CLL & Mantle Cell Lymphoma
ASH 2019 Interview - A/Prof Chan Cheah – Phase I study TG-1701 relapsed/refractory B-cell lymphoma
ASH 2019 Interview - Dr Stephen Ansell and Deborah Sims - Hodgkin Lymphoma
ASH 2019 Interview - Dr Brian Koffman - CLL updates & patient advocacy